Table of Contents Author Guidelines Submit a Manuscript
Cardiovascular Therapeutics
Volume 2019, Article ID 7372129, 10 pages
https://doi.org/10.1155/2019/7372129
Research Article

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF)

1China-Japan Friendship Hospital, Beijing, China
2Emergency and Intensive Care Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
3Cardiology Division, Beijing An Zhen Hospital, Capital Medical University, Beijing, China
4Department of Cardiology, Shanghai First People’s Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200080, China
5Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, 116000, China
6Department of Cardiology, Peking University People’s Hospital, Beijing, 100044, China

Correspondence should be addressed to Dayi Hu; moc.621@6102uhiyad

Received 28 September 2018; Revised 7 January 2019; Accepted 18 February 2019; Published 21 March 2019

Academic Editor: James C. Coons

Copyright © 2019 Yihong Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yihong Sun, Jun Zhu, Changsheng Ma, Shaowen Liu, Yanzong Yang, and Dayi Hu, “Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF),” Cardiovascular Therapeutics, vol. 2019, Article ID 7372129, 10 pages, 2019. https://doi.org/10.1155/2019/7372129.